Dihydrofolic Acid

Dihydrofolic Acid

SCHEMBL29510656

Nc1cc(N)ncn1.Nc1nc2c(c(=O)[nH]1)N=C(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)CN2

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMS P04818 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MEN1 O00255 1/20 0.56
ALDH1A1 P00352 1/20 0.56
POLB P06746 1/20 0.56
GAA P10253 1/20 0.56
AKR1B1 P15121 1/20 0.56
HPGD P15428 1/20 0.56
TSHR P16473 1/20 0.56
PTGS2 P35354 1/20 0.56
KMT2A Q03164 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
SOST Q9BQB4 1/20 0.56
DHFR P00374 3/20 0.56
GART P22102 5/20 0.54
ATIC P31939 3/20 0.54
MTHFD1 P11586 2/20 0.53
MTHFD2 P13995 1/20 0.51
FPGS Q05932 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dihydrofolic Acid SCHEMBL27589172 0.95 SOST (0.61) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL12136386 0.95 SOST (0.61) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL8282 0.95 SOST (0.61) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL8281 0.95 SOST (0.61) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL27415499 0.94 SOST (0.60) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL27779274 0.93 SOST (0.60) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL5159976 0.90 SOST (0.59) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL28796610 0.90 SOST (0.56) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL28902275 0.90 SOST (0.56) TYMSKDM4EMEN1ALDH1A1POLB
Dihydrofolic Acid SCHEMBL31299576 0.88 SOST (0.53) TYMSKDM4EMEN1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858946-B2 Small molecules active against gram-negative bacteria THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2024-01-02 US disclosed
US-20220112203-A1 SMALL MOLECULES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2022-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220112203-A1 SMALL MOLECULES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA PGLS, MRPL21, CLPP TYMS 2001/4885KDM4E 3454/4885MEN1 4703/4885
US-11858946-B2 Small molecules active against gram-negative bacteria PGLS, MRPL21, CLPP TYMS 2001/4885KDM4E 3454/4885MEN1 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.